Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
Prostaglandins, Leukotrienes, and Medicine|May 1, 1983
The effects of aspirin and dipyridamole on the metabolism of arachidonic acid in human plateletsP Uotila, M L Dahl, M Matintalo, et al.Therapeutic Drug Monitoring|June 1, 1992
Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizersA Llerena, M L Dahl, B Ekqvist, et al.Psychopharmacology|June 29, 2004
Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolismK I Melkersson, M-L Dahl, A-L HultingPharmacology & Toxicology|July 1, 1989
Glucuronidation of amitriptyline in man in vivoM L Dahl-Puustinen, A Aberg-Wistedt, L BertilssonTherapeutic Drug Monitoring|November 14, 1997
Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquineP Dalén, C Frengell, M L Dahl, et al.Acta Psychiatrica Scandinavica|July 1, 1991
Disposition of the neuroleptic zuclopenthixol cosegregates with the polymorphic hydroxylation of debrisoquine in humansM L Dahl, B Ekqvist, J Widén, et al.Amino Acids|July 30, 2008
Taurine in plasma and CSF: a study in healthy male volunteersM Samuelsson, M-L Dahl, R C Gupta, et al.Pharmacogenetics|August 1, 1996
PCR-based genotyping for duplicated and deleted CYP2D6 genesI Johansson, E Lundqvist, M L Dahl, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 1, 1988
Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivoM L Dahl-Puustinen, T Corell, K Koch, et al.The Pharmacogenomics Journal|November 14, 2012
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patientsM M Söderberg, T Haslemo, E Molden, et al.Pageof 11